ColoCare Study - Colorectal Cancer Cohort
ColoCare Transdisciplinary Research in Colorectal Cancer Prognosis
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years to 89 Years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Time periods mentioned: 5 years
- Procedures mentioned: Questionnaires
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "Patients are recruited at baseline (time of first diagnosis) and followed for up to 5 years at regular timepoints (3m, 6m, 12m, 24m, 36m, 48m, 60m)."
- "Furthermore, we will have an overall focus on questionnaire assessment at baseline, 12, and 60 months and intensive medical chart abstraction 24 months and 60. months after enrollment into the study."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
ColoCare is an international prospective cohort study of stage I-IV colorectal cancer patients (ICD-10 C18-C20).
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Official eligibility criteria
Inclusion Criteria: 1. Age 18-89 years; for patients recruited after 09/01/2021 the age range is 18-69 years. Recruitment of patients 70 years and older was maintained for specific sub-studies and re-initiated for specific R01 grant funding in \~06/2024 2. Men and women 3. Newly-diagnosed colon or rectal cancer (stages I-IV); CRC in treatment (FHCRC and HCI) 4. English (FHCRC, Moffitt, HCI, Cedars-Sinai, WashU St. Louis) or German (University Hospital Heidelberg)-speaking; 5. mentally/physically able to consent and participate. Exclusion Criteria: * if one of the above in not fulfilled * insufficient language or consent capacity
Study sites (6)
CA
- Cedars-Sinai Medical Center · Los Angeles, CA 90048Jane Figueiredo, PhD · Study contact · janefigu@usc.eduMore trials in Los Angeles
FL
- Lee H. Moffitt Cancer Center · Tampa, FL 12902Erin Siegel, PhD · Study contact · Erin.siegel@moffitt.orgMore trials in Tampa
MO
- Washington University School of Medicine · St Louis, MO 63112Adetunji T Toriola, MD, PhD · Study contact · a.toriola@wustl.eduMore trials in St Louis
TN
- University of Tennessee · Knoxville, TN 37996David Shibata, MD · Study contact · dshibata@uthsc.eduMore trials in Knoxville
UT
- Huntsman Cancer Institute · Salt Lake City, UT 84112Cornelia Ulrich, MS, PhD · Study contact · neli.ulrich@hci.utah.eduMore trials in Salt Lake City
WA
- FHCRC · Seattle, WA 98109-1024Christopher Li, MD, PhD · Study contact · cili@fhcrc.orgWilliam Grady, MD, PhD · Study contact · wgrady@fhcrc.orgMore trials in Seattle